Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Background: Most patients with autoimmune hepatitis respond to standard treatment with steroids and azathioprine. While the disease is usually fatal if untreated, patients who respond well to therapy have an excellent prognosis. Nevertheless, second-line treatment is necessary in approximately 20% o...

Full description

Bibliographic Details
Main Authors: Mirjam Kolev, Stefan Diem, Lara Diem, Susana G. Rodrigues, Annalisa Berzigotti, Guido Stirnimann, Nasser Semmo
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Journal of Translational Autoimmunity
Subjects:
Autoimmune hepatitis
Autoimmune liver disease
Mycophenolate mofetil
Azathioprine
Second line treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2589909022000338

Internet

http://www.sciencedirect.com/science/article/pii/S2589909022000338

Similar Items